Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block

Immune-related cardiotoxicities are uncommon but potentially fatal. The study aims to evaluate the value of pacemakers and methylprednisolone pulse therapy (MPPT) to patients with immune-related myocarditis concomitant with complete heart block (CHB). We first reviewed medical records of three patie...

Full description

Bibliographic Details
Main Authors:	Hu Chunhong, Zhao Lishu, Zhou Chengzhi, Wang Hanping, Jiang Shun, Li Yizheng, Peng Yurong, Deng Chao, Ma Fang, Pan Yue, Shu Long, Huang Yan, Zeng Yue, Wu Fang
Format:	Article
Language:	English
Published:	De Gruyter 2022-12-01
Series:	Open Medicine
Subjects:	immune checkpoint inhibitor myocarditis complete heart block pacemaker methylprednisolone pulse therapy
Online Access:	https://doi.org/10.1515/med-2022-0611

Similar Items

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves′s ophthalmopathy
by: Rajeev Philip, et al.
Published: (2013-01-01)

Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the Isfahan kashani hospital
by: Zahra Tolou-Ghamari, et al.
Published: (2013-01-01)

Bradycardia after pulse methylprednisolone therapy in a child—Uncommon side effect of a frequently used drug: A case report
by: Saroj K Tripathy, et al.
Published: (2023-01-01)

Acute lymphocytic myocarditis presenting as complete heart block in an adult: a case report
by: Thomas Camilleri, et al.
Published: (2023-08-01)

Anaesthetic management of pacemaker implantation in a child with dilated cardiomyopathy and acquired complete atrioventricular heart block
by: Garima Choudhary, et al.
Published: (2019-01-01)

Methylprednisolone pulse therapy: An alternative management of severe COVID-19
by: Patricia Merab Sauñe, et al.
Published: (2020-01-01)

Use of Pulse Therapy with Methylprednisolone and Plasmapheresis in Treatment of Autoimmune Ophthalmopathy Associated with Hyperthyroidism
by: O.I. Chernobrova, et al.
Published: (2013-10-01)

Efficacy of methylprednisolone pulse therapy in patients with COVID-19
by: zaicev_aa, et al.
Published: (2020-05-01)

Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study
by: Keum-Ju Choi, et al.
Published: (2023-02-01)

Longest lasting VVI pacemaker on the Indian subcontinent: Over 28.1 years of pacing without requiring pulse generator replacement
by: Rajneesh Calton, et al.
Published: (2018-10-01)

Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
by: Michael P. O’Shea, et al.
Published: (2023-09-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis
by: Krzysztof Cezary Lewandowski, et al.
Published: (2024-01-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

THE SPECIFICS AND WAY OF ATRIOVENTRICULAR BLOCK COURSE IN INFANTS MYOCARDITIS
by: E. S. Vasichkina, et al.
Published: (2016-01-01)

Feasibility of cardiac magnetic resonance imaging in temporary permanent pacemaker implants in pediatric myocarditis and complete atrioventricular block
by: Saikiran Kakarla, et al.
Published: (2024-04-01)

Methylprednisolone pulse therapy for critically ill patients with coronavirus disease 2019: A single‐center retrospective observational study
by: Hiromu Okano, et al.
Published: (2022-01-01)

Complete heart block due to diphtheritic myocarditis in the present era
by: Mithun J Varghese, et al.
Published: (2013-01-01)

Recurrent suspected myocarditis combined with infrahisian conduction disturbances revealing a desminopathy
by: Stéphane Boulé, MD, et al.
Published: (2015-09-01)

Comparative study of intravenous methylprednisolone pulse therapy versus oral prednisolone minipulse therapy in progressive vitiligo
by: K A Rajeshwari, et al.
Published: (2023-01-01)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
by: Nicolas Palaskas, et al.
Published: (2020-01-01)

Treatment of Methylprednisolone Allergy with Dexamethasone
by: Öner Özdemir, et al.
Published: (2017-06-01)

A simple, wide bandwidth, biopotential amplifier to record pacemaker pulse waveform
by: Bifulco P, et al.
Published: (2016-09-01)

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
by: Muhammet Gürdoğan, et al.
Published: (2020-07-01)

Methylprednisolon acetate in the management of
by: N. Khaci, M.D., et al.
Published: (2008-01-01)

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study
by: I Z Gaydukova, et al.
Published: (2015-05-01)

High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study
by: Carsten Zeiner, et al.
Published: (2023-10-01)

Experience of treating congenital complete atrioventricular block with epicardial pacemaker in infants and young children: a retrospective study
by: Linhong Song, et al.
Published: (2023-11-01)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)

Evolution of cardiac pacemakers: a journey from Galvanic experiments to leadless pacemakers
by: Abay Bakytzhanuly
Published: (2023-08-01)

Leadless pacemaker – A savior in crisis
by: Ashwin Tumkur, et al.
Published: (2023-01-01)

Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
by: Kaho Akiyama, et al.
Published: (2021-06-01)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
by: Marcelo Bragança dos Reis Oliveira, et al.
Published: (2018-10-01)

Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
by: Fereshteh Ashtari, et al.
Published: (2021-07-01)

The Clinical Features of Children With Acute Fulminant Myocarditis and the Diagnostic and Follow-Up Value of Cardiovascular Magnetic Resonance
by: Jianli Lv, et al.
Published: (2019-10-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
by: Mariana Mirabel, MD, PhD, et al.
Published: (2020-09-01)

A systematic review of myasthenia gravis complicated with myocarditis
by: Wei Cheng, et al.
Published: (2021-08-01)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves′ orbitopathy: A randomized controlled trial
by: Ajitesh Roy, et al.
Published: (2015-01-01)

Successful Therapy for Myocarditis Concomitant With Complete Heart Block After Pembrolizumab Treatment for Head and Neck Squamous Cell Carcinoma: A Case Report With Literature Review
by: Lina Su, et al.
Published: (2022-05-01)

The Effect of Methylprednisolone Acetate Injection at Cervical Trigger Points in both Chronic and Drug Resistant Headache
by: MJ Hadianfard, et al.
Published: (2011-06-01)